Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixekizumab Phase 4 Study in Japan (details not reported)
jRCT1080224735Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of ixekizumab, sponsored by Eli Lilly and Company. Started Jun 2019; status: completed.
02
Drugs
ixekizumab
Beyond the preview
Go deeper on jRCT1080224735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224735.